AIM: In recent years, we have seen a considerable increase in the relevance of nanostructures for the safe delivery of therapeutic agents and their capacity as an immunomodulatory tool. MATERIALS AND METHODS: Potential clinical applications related to their unique structural properties have been described in the evolving landscape of immunotherapy. RESULTS: This review briefly summarizes the evidence for the role of nanoparticles in regulating the immune response. CONCLUSIONS: Their main features to highlight how to provide an innovative means of biomedical application to oncology research.
No takes yet. Share an insight, caveat, or question.
López‐Campos et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: